Cancer News and Research

Latest Cancer News and Research

Radiation therapy to combat early-stage prostate cancer does not affect sexual and urinary function

Men receiving radiation therapy to combat early-stage prostate cancer are still able to achieve an erection and face a low rate of incontinence one year following treatment, according to a new study published in the July 15, 2005 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.

17 Jul 2005

Malpractice litigation has little to do with erratic quality of health care

Conventional wisdom holds that malpractice lawsuits are the bane of modern medicine, with high insurance premiums driving doctors from the profession and the threat of lawsuits discouraging health-care employees from reporting and correcting medical mistakes.

17 Jul 2005

Asian American and Pacific Island women less likely to receive breast-conserving surgery

Asian American and Pacific Island women, particularly those born abroad, are less likely to receive breast-conserving surgery for early-stage breast cancer than non-Hispanic white women, according to a study published in the online Journal of General Internal Medicine.

17 Jul 2005

Individuals with inactive heterozygous ALDH2, a tendency to alcohol flushing have a greater susceptibility to hangovers

Alcohol consumption is an integral part of the Japanese business culture. Hangovers, however, can have substantial economic drawbacks.

17 Jul 2005

PGE2 may be a target for Celebrex therapy

A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer, according to a study by researchers at UCLA's Jonsson Cancer Center.

17 Jul 2005

Novel treatment for ovarian cancer

The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States.

15 Jul 2005

Having asthma, hay fever or another allergic condition may reduce the risk of developing Glioblastoma multiforme

Glioblastoma multiforme (GBM) affects three out of 100,000 people, a rate that quadruples to 13 out 100,000 among people who are 65 and older. The average five-year survival rate from the time of diagnosis for GBM is only 3.3 percent, and is lower for people 65 and older.

15 Jul 2005

Asbestos in rocks cause lung cancer

According to a study by a team at UC Davis Department of Public Health Sciences, everyday exposure to naturally occurring asbestos, increases the risk of developing malignant mesothelioma.

14 Jul 2005

At the end of life hospices better option for the elderly than nursing homes

A new study has shown that straight talking elderly people, who are facing death in nursing homes, raises the likelihood of them agreeing to enter hospices in the last days of their life.

14 Jul 2005

Erlotinib increases survival in patients with advanced non-small cell lung cancer

An international clinical study led by Canadian researchers has demonstrated that a drug called erlotinib increases survival in patients with advanced non-small cell lung cancer who typically have no other treatment options.

13 Jul 2005

New search method could aid in the discovery of biomarkers for breast cancer

Using a super-efficient method they invented to search for a type of cancer-related change in all genes of a cell, Dana-Farber Cancer Institute researchers have discovered new evidence about how the "microenvironment" of breast cancers helps drive the cancers' growth and migration.

13 Jul 2005

New method may accelerate the way cancer-causing genes are found

Researchers at the University of Minnesota Cancer Center and the National Cancer Institute (NCI) have discovered a new method that could accelerate the way cancer-causing genes are found and could lead to a more accurate identification of the genes, according to two studies in the July 14, 2005, issue of Nature.

13 Jul 2005

Stressgen granted U.S. patent providing coverage for the manufacture of HspE7

Stressgen Biotechnologies announced today that the U.S. Patent and Trademark Office granted US Patent Number 6,900,035, covering methods of manufacturing HspE7, the Company's lead product candidate for human papillomavirus (HPV)- related diseases and cancer.

13 Jul 2005

Hospice referral rates increase with intervention

A simple information and communication intervention between a patient and physician can increase hospice referral rates among nursing home residents, increase their families' ratings of end-of-life care, and may decrease use of acute care resources, according to an article in the July 13 issue of JAMA: The Journal of the American Medical Association.

13 Jul 2005

Mesothelioma may be caused by exposure to ultramafic rock

Everyday exposure to naturally occurring asbestos increases the risk of developing malignant mesothelioma, according to a study by UC Davis researchers.

13 Jul 2005

Women beware of black cohosh, red clover and ginseng!

Women who take soy or herbal supplements, such as black cohosh, red clover and ginseng, should do so with care, says a Cornell University expert affiliated with the Program on Breast Cancer and Environmental Risk Factors (BCERF) at Cornell, the land-grant institution of New York state.

13 Jul 2005

Female lung cancer in Europe rising

The first comprehensive picture of female lung cancer mortality trends in Europe shows rates are still rising in most countries. But, the research does indicate that there is some room for cautious optimism in the longer term due to decreases or smaller rates of increase in some countries and a more favourable trend among younger women in many countries.

13 Jul 2005

Approval sought for Femara in early post-surgery use

Approval is being sought in the U.S. and Europe, by Swiss drug makerNovartis, for its breast-cancer drug Femara to be used immediately after surgery to help older women fight tumours.

12 Jul 2005

Menopause symptoms return with a vengence when women stop HRT

In somewhat depressing news for women battling that often miserable phase in their lives, the menopause, it appears that more than half of women who start taking hormone replacement therapy to relieve the discomfort, can expect to see a dramatic resurgence of those symptoms, when they discontinue the therapy.

12 Jul 2005

Curcumin has potent anticancer powers

Curcumin, a spice commonly used in curries and other south Asian cooking, blocks a key biological pathway needed for development of melanoma and other cancers, say researchers from the University of Texas M. D. Anderson Cancer Center.

12 Jul 2005